Maria E. Chavez-Icaza

Merida, YUC, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Clinical guideline of the Asociación Mexicana de Gastroenterología for the diagnosis and treatment of lactose ingestion-related disorders.

Clinical guideline of the Asociación Mexicana de Gastroenterología for the diagnosis and treatment of lactose ingestion-related disorders.

Journal: Revista de gastroenterologia de Mexico (English)

Published: October 17, 2025

Adjusted prevalence of metabolic-associated steatotic liver disease (MASLD) in a Mexican.

Adjusted prevalence of metabolic-associated steatotic liver disease (MASLD) in a Mexican.

Journal: Revista de gastroenterologia de Mexico (English)

Published: July 04, 2025

Metabolic index a non-invasive predictive marker of liver steatosis in patients with Non-Alcoholic Fatty Liver Disease

Metabolic index a non-invasive predictive marker of liver steatosis in patients with Non-Alcoholic Fatty Liver Disease

Journal: Medicina clinica

Published: April 14, 2025

Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024.

Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024.

Journal: Revista de gastroenterologia de Mexico (English)

Published: September 12, 2024

Transitioning from NAFLD to MAFLD to MASLD in the Mexican population.

Transitioning from NAFLD to MAFLD to MASLD in the Mexican population.

Journal: Revista de gastroenterologia de Mexico (English)

Published: June 11, 2024

Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort.

Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort.

Journal: Clinics and research in hepatology and gastroenterology

Published: May 05, 2024

Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD.

Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD.

Journal: Revista de gastroenterologia de Mexico (English)

Published: December 04, 2023

The Mexican consensus on fecal incontinence.

The Mexican consensus on fecal incontinence.

Journal: Revista de gastroenterologia de Mexico (English)

Published: July 25, 2023

Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?

Is the Sars-CoV-2 virus a possible trigger agent for the development of achalasia?

Journal: Neurogastroenterology and motility

Published: September 26, 2022

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease.

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease.

Journal: World journal of hepatology

Published: February 17, 2022

Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease.

Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease.

Journal: European journal of gastroenterology & hepatology

Published: August 17, 2021

Body composition and phase angle by bioimpedance in patients with MAFLD.

Body composition and phase angle by bioimpedance in patients with MAFLD.

Journal: Gastroenterologia y hepatologia

Published: August 02, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026